PathAI locks in $165m Series C

PathAI, a provider of artificial intelligence-powered technology for pathology, has secured $165 million in Series C financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this